Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients

The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US.

Related Keywords

David Lanfear ,Henry Ford ,Drug Administration ,Henry Ford Health ,Clinical Pharmacogenetics Implementation Consortium ,American College Of Medical Geneticists ,Fulgent Genetics ,American College ,Medical Geneticists ,